Adaptive Biotechnologies (ADPT) Retained Earnings (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Retained Earnings of $1.6 billion for Q1 2026, up 1.13% sequentially from $1.6 billion in Q4 2025, and up 4.97% YoY from $1.5 billion in Q1 2025.
Adaptive Biotechnologies (ADPT) Retained Earnings (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Retained Earnings for 9 years, with the latest figure at $1.6 billion in Q1 2026.
- Quarterly Retained Earnings rose 4.97% year-over-year to $1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 4.97% YoY) and the FY2025 annual result came in at $1.6 billion, up 952820.48% from the prior year.
- Retained Earnings advanced to $1.6 billion in Q1 2026 per ADPT's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $1.6 billion in Q1 2026 and troughed at -$1.2 billion in Q2 2024.
- A 5-year average of $464.1 million and a median of $1.3 billion in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings plunged 187.1% in 2024, then soared 952820.48% in 2025.
- Over 5 years, Retained Earnings stood at -$919.1 million in 2022, then surged by 100.02% to $215000.0 in 2023, then dropped by 22.79% to $166000.0 in 2024, then jumped by 952820.48% to $1.6 billion in 2025, then increased by 1.13% to $1.6 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $1.6 billion, $1.6 billion, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 62.19 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 48.23 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 7.01 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.69 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 7.96 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -202,000.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 7.93 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 9.64 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.37 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 1.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Bn |
| Dec 31, 2025 | 1.58 Bn |
| Sep 30, 2025 | 1.55 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Mar 31, 2025 | 1.52 Bn |
| Dec 31, 2024 | 166,000.00 |
| Sep 30, 2024 | 497,000.00 |
| Jun 30, 2024 | -1.24 Bn |
| Mar 31, 2024 | -1.19 Bn |
| Dec 31, 2023 | 215,000.00 |
| Sep 30, 2023 | -1.07 Bn |
| Jun 30, 2023 | 1.42 Bn |
| Mar 31, 2023 | -976.78 Mn |
| Dec 31, 2022 | -919.08 Mn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.36 Bn |
| Mar 31, 2022 | 1.34 Bn |
| Dec 31, 2021 | 1.32 Bn |
| Sep 30, 2021 | 1.31 Bn |
| Jun 30, 2021 | 1.29 Bn |